Skip to main content
Dermatology
ALL Specialities
ALL Specialities
/
Dermatology
Cutis
Current and Past Issues
For Authors
CME
COVID-19 Updates
Diseases & Conditions
Acne
Actinic Keratosis
Aesthetic Dermatology
Atopic Dermatitis
Autoimmune Diseases
Contact Dermatitis
Hair & Nails
Melanoma
Nonmelanoma Skin Cancer
Pigmentation Disorders
Psoriasis
Psoriatic Arthritis
Rare Diseases
Rosacea
Urticaria
Wounds
Conference Coverage
Quizzes
Dermpath Diagnosis
Diagnose This
Make the Diagnosis
MD-IQ
Pediatric Dermatology Consult
Photo Challenge
Multimedia
Audio
All MDedge Podcasts
Dermatology Weekly
Video
Procedural Videos
News
Biosimilars poised to make biologics more routine
Publish date:
October 16, 2014
References
mzoler@frontlinemedcom.com
On Twitter
@mitchelzoler
Pages
« first
1
2
3
Recommended Reading
Anti-adalimumab antibodies mean poorer outcomes in psoriatic arthritis
MDedge Dermatology
Neuronal autoantibodies may contribute to hippocampal atrophy in SLE, Sjögren’s
MDedge Dermatology
Psoriatic arthritis patients often changed or stopped treatment
MDedge Dermatology
Minimal disease activity in psoriatic arthritis is a realistic target
MDedge Dermatology
VIDEO: New diagnostic criteria catch systemic lupus earlier
MDedge Dermatology
Uncertainty remains over importance of subtle hydroxychloroquine eye changes
MDedge Dermatology
Look to presentation, not pathology, for dermatomyositis diagnosis
MDedge Dermatology
Three years of prednisone can trigger cataracts in lupus patients
MDedge Dermatology
Drug combos for psoriatic arthritis upped shingles risk
MDedge Dermatology
High-resolution MRI revealed enthesitis in PsA patients with dactylitis
MDedge Dermatology
Psoriatic Arthritis
Psoriasis
All Specialties
